Latest Breaking News On - Genetics stock down - Page 1 : comparemela.com

Myriad Genetics, Inc. (NASDAQ:MYGN) Director Daniel K. Spiegelman Sells 3,788 Shares

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) Director Daniel K. Spiegelman sold 3,788 shares of Myriad Genetics stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $22.04, for a total transaction of $83,487.52. Following the sale, the director now directly owns 36,705 shares in the company, […]

United statesPiper sandlerLeerink partnrsDanielk spiegelmanJefferies financial groupAllspring global investments holdingsChina universal asset management coBlue trust incGenetics incAmeritas investment partners incMyriad geneticsGet free reportDirector danielGenetics stock downInvestment partnersGlobal investments holdings

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance

Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesGoldman sachs groupGenetics incMyriad geneticsGet free reportGenetics stock downMyrisk hereditary cancer testGermline companion diagnostic testCompanion diagnostic testMyriad genetics daily

Myriad Genetics (NASDAQ:MYGN) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Myriad Genetics (NASDAQ:MYGN) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Federated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,009 shares of the company’s stock after selling 1,533 shares during the quarter. […]

United statesNew zealand generalNew zealandGoldman sachs groupQube research technologies ltdInvesco ltdWellington management groupDeutsche bankGenetics incJump financialHermes incExchange commissionFederated hermesMyriad geneticsFree reportManagement group

Myriad Genetics, Inc. (NASDAQ:MYGN) Given Average Rating of "Hold" by Brokerages

Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]

United statesNew zealand generalNew zealandSei investments coWellington management groupGenetics company profileGenetics incEarnest partnersGoldman sachs groupGlenview capital managementVanguard group incMyriad geneticsGet free reportGenetics stock downCapital managementManagement group